Basal metabolic rate in morbidly obese patients with non-alcoholic fatty liver disease

Clinical and Investigative Medicine

Volumn 31, Issue 1, 2008, Pages

  Tarantino, Giovanni ^a   Marra, Maurizio ^a   Contaldo, Franco ^a   Pasanisi, Fabrizio ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; FIBRINOGEN; INTERLEUKIN 6;

ADULT; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BASAL METABOLIC RATE; CALORIMETRY; CELL DEATH; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; ECHOGRAPHY; ENERGY EXPENDITURE; FIBRINOGEN BLOOD LEVEL; HUMAN; HYPERTENSION; INFLAMMATION; INTRAABDOMINAL FAT; LABORATORY TEST; MALE; MORBID OBESITY; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ABDOMINAL FAT; ADIPOSITY; ADOLESCENT; ADULT; ENERGY METABOLISM; FATTY LIVER; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; MALE; METABOLIC SYNDROME X; OBESITY, MORBID;

EID: 39449083509     PISSN: 0147958X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Colicchio P, Tarantino G, Del Genio F, et al. Nonalcoholic Fatty liver disease in young adult severely obese non-diabetic patients in South Italy. Ann Nutr Metab. 2005;49:289-95.
2. Ratziu V, Charlotte F, Heurtier A, et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 2005;128:1898-906.
3. Palmentieri B, de Sio I, La Mura V, et al. The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis. Dig Liver Dis. 2006;38:485-9.
4. Targher G, Arcaro G. Non-alcoholic fatty liver disease and increased risk of cardiovascular disease. Atherosclerosis 2007;191:235-40.
5. Zamin I Jr, de Mattos AA, Zettler CG. Nonalcoholic steatohepatitis in nondiabetic obese patients. Can J Gastroenterol. 2002;16:303-7.
6. Schneider AR, Kraut C, Lindenthal B, Braden B, Caspary WF, Stein J. Total body metabolism of 13C-octanoic acid is preserved in patients with nonalcoholic steatohepatitis, but differs between women and men. Eur. J. Gastroenterol Hepatol. 2005;17:1181-4.
7. Uchino S, Yamaguchi Y, Furuhashi T et al. Steatotic liver allografts up-regulate UCP-2 expression and suffer necrosis in rats. J Surg Res. 2004;120:73-82.
8. Schneeweiss B, Graninger W, Ferenci P, et al. Energy metabolism in patients with acute and chronic liver disease. Hepatology 1990;11:387-93.
9. Shetty P. Energy requirements of adults. Public Health Nutr. 2005;8:994-1009.
10. Pradhan AD, Manson JE, Rossouw JE et al. Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study. JAMA 2002;288:980-7
11. de Maat MP, Pietersma A, Kofflard M, Sluiter W, Kluft C. Association of plasma fibrinogen levels with coronary artery disease, smoking and inflammatory markers. Atherosclerosis 1996;121:185-91.
12. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
13. Mathiesen UL, Franzen LE, Aselius H, et al. Increased liver echogenicity at ultrasound examination reflects degree of steatosis but not of fibrosis in asymptomatic patients with mild/moderate abnormalities of liver transaminases. Dig Liver Dis. 2002;34:516-22.
14. Lukaski HC, Bolonchuk WW, Hall CB, Siders WA. Validation of a tetrapolar bioelectrical impedance method to assess human body composition. J Appl Physiol 1986: 60:1327-32.
15. DG Carey DG, Pliego GJ, Raymond RL. Body composition and metabolic changes following bariatric surgery: effects on fat mass, lean mass and basal metabolic rate: six months to one-year follow-up. Obes Surg. 2006;16:1602-8.
16. Cancello R, Tounian A, Poitou Ch, Clement K. Adiposity signals, genetic and body weight regulation in humans. Diabetes Metab. 2004;30:215-27
17. Begriche K, Igoudjil A, Pessayre D, Fromenty B. Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it. Mitochondrion. 2006;6:1-28.
18. Markus HS, Cox M, Tomkins AM. Raised resting energy expenditure in Parkinson's disease and its relationship to muscle rigidity. Clin Sci 1992;83:199-204
19. García-Galiano D, Sánchez-Garrido MA, Espejo I, et al. IL-6 and IGF-1 are independent prognostic factors of liver steatosis and non-alcoholic steatohepatitis in morbidly obese patients. Obes Surg. 2007;17:493-503.
20. Das SK, Saltzman E, McCrory MA, et al. Energy expenditure is very high in extremely obese women. J Nutr. 2004;134:1412-6.